PATENT CLAIM ANALYSIS

Application Number: 15743133
Application Type: Utility
Filing Date: 2018-01
Publication Date: 2019-04
Patent Classification: ["424", "204100"]

Abstract:
The invention relates to methods, compositions, and kits for treating a condition with an immune response modifier and a human papillomavirus (HPV) vaccine. Conditions treatable with the methods, kits and compositions include but are not limited to neoplasia, anal intraepithelial neoplasia, high-grade squamous intraepithelial neoplasia, dysplasia, anal dysplasia, dysplastic lesion, high-grade dysplastic lesion, condyloma, anal cancer, anal tumor, HPV infection, and any HPV-induced condition.

Claim (Index 24):
The method of  claim 1 , wherein the HPV vaccine is a vaccine protective against HPV 6, 11, 40, 42, 43, 44, 53, 54, 61, 72, 73, 81, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, or 68, or a combination thereof.

Metadata:
- Claim Count in Document: 87.0
- Percentile: 86.0
- Lexical Diversity: 1.74468
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15701872', '14932789', '15448924', '15242383', '15601278']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7466808133996037
- 35 USC 102 Novelty (BERT): 0.482170986376815
- Combined Prediction Score: 0.7202298306973248
- Mean Citation Score: 241.845594
- Max Citation Score: 245.23358
- Similarity Product: 221.3863721342182

Labels:
- Claim Label 101: 1
- Claim Label 102: 0
- Claim Label 103: 0
- Claim Label 112: 0
- Combined Label: 0
- Label 101 Adjusted: 1

Dataset: test